vs
Side-by-side financial comparison of MANGOCEUTICALS, INC. (MGRX) and TREASURE GLOBAL INC (TGL). Click either name above to swap in a different company.
TREASURE GLOBAL INC is the larger business by last-quarter revenue ($182.5K vs $94.4K, roughly 1.9× MANGOCEUTICALS, INC.). TREASURE GLOBAL INC runs the higher net margin — -1169.1% vs -2935.1%, a 1766.0% gap on every dollar of revenue. On growth, MANGOCEUTICALS, INC. posted the faster year-over-year revenue change (-10.3% vs -12.0%). Over the past eight quarters, MANGOCEUTICALS, INC.'s revenue compounded faster (-33.6% CAGR vs -83.5%).
MANGOCEUTICALS, INC. is a men's health and personal care company that develops, manufactures, and distributes science-backed consumer products, including dietary supplements, skincare, and hair care solutions targeted at common male wellness needs. It mainly operates in the U.S. market, selling via direct-to-consumer e-commerce platforms and select retail partners, prioritizing accessible, transparent wellness offerings for adult male consumers.
Treasure Global Inc is a consumer technology company offering integrated digital commerce solutions, customer loyalty rewards programs, and cashless payment services. It primarily operates across Southeast Asian markets, serving individual users and small-to-medium enterprise clients.
MGRX vs TGL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $94.4K | $182.5K |
| Net Profit | $-2.8M | $-2.1M |
| Gross Margin | 50.3% | 0.7% |
| Operating Margin | -389.7% | -953.5% |
| Net Margin | -2935.1% | -1169.1% |
| Revenue YoY | -10.3% | -12.0% |
| Net Profit YoY | -42.1% | -124.5% |
| EPS (diluted) | $0.38 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $94.4K | — | ||
| Q3 25 | $84.2K | $182.5K | ||
| Q2 25 | $168.1K | $1.2M | ||
| Q1 25 | $109.3K | $666.5K | ||
| Q4 24 | $105.2K | $301.9K | ||
| Q3 24 | $133.4K | $207.4K | ||
| Q2 24 | $163.2K | $293.0K | ||
| Q1 24 | $214.1K | $1.6M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-7.6M | $-2.1M | ||
| Q2 25 | $-5.4M | — | ||
| Q1 25 | $-4.8M | $1.3M | ||
| Q4 24 | $-1.9M | $-232.3K | ||
| Q3 24 | $-2.0M | $-950.7K | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-2.4M | $-1.7M |
| Q4 25 | 50.3% | — | ||
| Q3 25 | 60.4% | 0.7% | ||
| Q2 25 | 53.5% | 68.2% | ||
| Q1 25 | 56.8% | 73.0% | ||
| Q4 24 | 76.1% | 74.2% | ||
| Q3 24 | 62.0% | 83.0% | ||
| Q2 24 | 42.8% | 31.0% | ||
| Q1 24 | 68.8% | 13.6% |
| Q4 25 | -389.7% | — | ||
| Q3 25 | -8953.5% | -953.5% | ||
| Q2 25 | -3134.0% | — | ||
| Q1 25 | -4440.0% | -6.5% | ||
| Q4 24 | -1594.0% | -229.5% | ||
| Q3 24 | -1318.2% | -391.4% | ||
| Q2 24 | -1329.1% | — | ||
| Q1 24 | -1105.9% | -85.9% |
| Q4 25 | -2935.1% | — | ||
| Q3 25 | -9042.8% | -1169.1% | ||
| Q2 25 | -3221.6% | — | ||
| Q1 25 | -4427.4% | 189.0% | ||
| Q4 24 | -1851.2% | -77.0% | ||
| Q3 24 | -1499.0% | -458.5% | ||
| Q2 24 | -1465.4% | — | ||
| Q1 24 | -1105.9% | -107.3% |
| Q4 25 | $0.38 | — | ||
| Q3 25 | $-0.69 | $-0.38 | ||
| Q2 25 | $-0.57 | — | ||
| Q1 25 | $-1.29 | $1.09 | ||
| Q4 24 | $-0.79 | $-11.32 | ||
| Q3 24 | $-1.14 | $-17.62 | ||
| Q2 24 | $-1.37 | — | ||
| Q1 24 | $-1.50 | $-116.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.2M | $12.0M |
| Total Assets | $16.1M | $16.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | — | ||
| Q3 25 | $481.3K | — | ||
| Q2 25 | $101.0K | — | ||
| Q1 25 | $76.5K | $2.5K | ||
| Q4 24 | $58.7K | $504.3K | ||
| Q3 24 | $73.9K | $44.1K | ||
| Q2 24 | $490.2K | $171.6K | ||
| Q1 24 | $15.3K | — |
| Q4 25 | $15.2M | — | ||
| Q3 25 | $15.7M | $12.0M | ||
| Q2 25 | $19.2M | $10.7M | ||
| Q1 25 | $20.3M | $29.1M | ||
| Q4 24 | $13.9M | $18.4M | ||
| Q3 24 | $13.4M | $6.3M | ||
| Q2 24 | $13.8M | $3.4M | ||
| Q1 24 | $-958.4K | $3.1M |
| Q4 25 | $16.1M | — | ||
| Q3 25 | $16.5M | $16.6M | ||
| Q2 25 | $20.8M | $14.9M | ||
| Q1 25 | $21.8M | $30.4M | ||
| Q4 24 | $15.4M | $19.1M | ||
| Q3 24 | $14.8M | $7.1M | ||
| Q2 24 | $15.2M | $4.3M | ||
| Q1 24 | $301.4K | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $-1.8M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -1318.2% |
| Capex IntensityCapex / Revenue | — | 353.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $-1.2M | $-1.8M | ||
| Q2 25 | $-1.3M | $-9.5M | ||
| Q1 25 | $-2.3M | $-4.2M | ||
| Q4 24 | $-1.1M | $-606.2K | ||
| Q3 24 | $-1.2M | $-976.3K | ||
| Q2 24 | $-1.6M | $-4.7M | ||
| Q1 24 | $-991.1K | $-1.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-2.4M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-1.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | -1318.2% | ||
| Q2 25 | — | -822.4% | ||
| Q1 25 | — | -635.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1614.2% | ||
| Q1 24 | — | -67.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 353.3% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -3.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
